083790.KQ
CG Invites Co., Ltd.
KOE · Healthcare · Biotechnology · KR
KRW 843.00
+0.12%Year over year
Reported trailing growth
- Revenue
- +98.4%
- EBITDA
- +26.1%
- EBIT
- +41.2%
- EPS
- +100.8%
- Free cash flow
- +85.0%
- Operating cash flow
- +88.0%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +85.1%
- EBITDA
- +59.8%
- EBIT
- +39.0%
- Net income
- +93.2%
- EPS
- +93.1%
- Free cash flow
- +43.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026